Letter to the Editor
Copyright ©The Author(s) 2025.
World J Diabetes. May 15, 2025; 16(5): 103447
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.103447
Table 1 Comparison of three most commonly used surgical treatments

Jejunoileal side-to-side anastomosis
Roux-en-Y gastric bypass
sleeve gastrectomy
Targeting the crowdIt is mainly targeted at T2DM patients with normal or relatively high BMI and comorbiditiesIt is primarily targeted at T2DM patients with high BMI and comorbiditiesIt is primarily targeted at T2DM patients with high BMI and with or without comorbidities
EffectivenessEffectively alleviates T2DM and related comorbiditiesSignificant weight loss and effective reduction of T2DM and related comorbiditiesThe weight loss outcomes were substantial; however, the improvement in comorbidities was less pronounced compared to Roux-en-Y gastric bypass
SafetyIt may cause long-term nutrient absorption problems due to intestinal reconstruction, but there are few clinical studies and no obvious data supportEarly complications include: Anastomotic leak, hemorrhage obstruction
Venous thrombo-embolic disease. Infections: Late complications include: Internal herniation (most common). Stricture. Micronutrient deficiency. Hyperoxaluria. Gallstone formation. Dumping syndrome. Marginal ulcers. Gastrogastric fistula. Failed weight loss maintenance. Roux-en-Y Gastric Bypass has a higher mortality rate of about 0.2% than sleeve gastrectomy
The complication rate is low but there may be problems with gastroesophageal reflux
Cost-effectivenessSurgery is shorter and hospital stays less, so initial costs are lower, but costs for long-term nutritional management may increaseAlthough surgery costs are high, medical expenses may be reduced in the long term due to diabetes remissionIn between